19.7 C
Tuesday, December 6, 2022

Grant Opportunities: Japan Smart Healthy Aging QuickFire Challenge ($300,000 in total funding)

Must read

Deadline: 2-Dec-22

Innovators from across the globe are invited to submit promising science or technologies that aim to potentially increase healthy life expectancy – to help people live longer, happier lives.

To inspire smart healthy aging potential solutions, Johnson & Johnson Innovation, together with The Johnson & Johnson Family of Companies in Japan is proud to launch the Japan Smart Healthy Aging QuickFire Challenge.

Johnson & Johnson’s Smart Healthy Aging Initiative, a cross-sector initiative by the Japan Presidents Council, aims to help improve the lives of the elderly by connecting other partners from hospital institutions, academia, government, business and the healthcare industry to expand both the breadth and depth of J&J’s offerings with the goal of delivering a truly holistic approach to Healthy Aging.

The aim to identify and catalyze cross-disciplinary ideas with the patient journey as their guide. Innovations range from potential solutions that aim to accelerate early detection and intervention to ideas that can improve adherence to treatment and lower the risk of recurrence.

By uniting the entire healthcare ecosystem to target complex disease areas with a multidisciplinary approach, their goal is to discover the next most impactful potential solution.

Funding Information
  • Grant funding from a total pool of $300,000.
What they’re looking for

Innovators from across the globe are invited to submit promising science or technologies that aim to potentially increase healthy life expectancy to help people live longer, happier lives. Potential solutions should focus on the areas of preventing, intercepting, and curing complex disease to deliver a truly holistic approach to healthy aging. They have a particular interest in the following areas:

  • Vision, areas including
    • Cataract surgery and corneal refractive surgery including amongst others:
      • Intraocular lenses  (IOL’s): Extending range and quality of vision, accommodation and adjustability
      • Novel refractive surgery technologies
      • Streamlining cataract and refractive surgical work flow for improved efficiency and patient outcomes
    • Contact lens technologies including amongst others:
      • Novel presbyopia solutions for improved range of vision
      • Presbyopia patient screening and fitting methods to improve eye care practitioner (ECP) fitting success
      • Improve patient experience and vision outcomes with multifocal lenses
      • Light management approaches to improve vision and ocular health
    • ​​​​​​​Ocular drug delivery technologies for anterior and posterior segment diseases and ocular health
  • Oncology:
    • Technologies and novel approaches to improve the management of Bladder, Lung, Colorectal, and hematological cancers, such as:
      • Development of digital biomarkers: Physiologic (i.e., biometric based) and QoL (e.g.,ADLs, emotional wellbeing) driven endpoints; ePROs, biometric
      • Remote monitoring solutions to support decentralized clinical trials and remote patient care, including home testing for treatment response / adverse events
    • Technologies that improve prognostic forecast, treatment selection, or overall patient stratification, E.g., Computer vision algorithms applied to digitized histopathology or radiology data
    • Approaches for engaging with aging populations for the generation of rich longitudinal RWE and recruitment to clinical trials, with connectivity to additional data sources/types such as EHR, imaging, speech, video, etc. (not just patient reported)
  • Orthopedics including osteoarthritis:
    • Validated novel technologies that can predict early onset stage of osteoarthritis
    • Products/Technologies to predict post-operative outcomes and quality of life
    • Products/Technologies to promote recovery through individualized comprehensive pre-operative and post-operative programs (e.g. Physical and psychological)
  • Digital surgery:
    • Technologies (Advanced visualization, Artificial intelligence, robotics, AR/VR/XR) that enable minimally invasive and/or shorter procedure time, which lead to safer and better patient experience and outcomes.
  • Neurovascular:
    • Early detection of stroke and determination of hemorrhagic or ischemic classification
    • Fast, easy and minimally invasive screening for stroke risk and vascular disease
Eligibility Criteria
  • Potential solutions will be evaluated by a panel of reviewers and judges on their ability to meet the following criteria:
    • Potential impact and relevance to elderly populations
    • Uniqueness of potential solution & level of competition in current market
    • Quality & feasibility of technology
    • Team credibility & capabilities
    • Potential solution is validated
    • Idea submission outlines interest in the innovation ecosystem in Japan
    • Ability to realize returns in the next 2 to 3 years
    • Each Challenge has its own terms & conditions that can be found prior to filling out the application and that need to be accepted in order to be able to participate.
    • Please Note, while all potential applicants are encouraged to apply, those that are Health Care Providers (“HCPs”), Government Officials (“GOs”) or any organization affiliated with either, including but not limited to 501c3 and/or 501c4 entities, will be subjected to additional review and may not be ultimately eligible to participate or to receive the award per local laws, regulations and industry guidelines.

For more information, visit https://jnjinnovation.com/innovation-challenges/japan-smart-healthy-aging-quickfire-challenge

- Advertisement -spot_img

More articles


Please enter your comment!
Please enter your name here

- Advertisement -spot_img

Latest article